Analysis of Biopharmaceutical Manufacturing Localisation in Russia Considering the Country of Origin of Active Pharmaceutical Ingredients

Analysis of Biopharmaceutical Manufacturing Localisation in Russia Considering the Country of Origin of Active Pharmaceutical Ingredients

SCIENTIFIC RELEVANCE. Russia is pursuing a consistent government policy of import substitution and increasing the localisation of pharmaceutical manufacturing. The Strategy for the Development of the Pharmaceutical Industry until 2030 (Pharma-2030) includes the target share of medicinal products fro...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Khalimova, A. S. Orlov, A. A. Taube
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2024-02-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
ppharmaceutical market
biotechnological medicinal products
localisation of production
import dependence
strategic medicines
active pharmaceutical ingredients
antibiotics
hormones
monoclonal antibodies
Online Access:https://www.vedomostincesmp.ru/jour/article/view/597
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.vedomostincesmp.ru/jour/article/view/597

Similar Items